Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Psychiatry. 2002;63 Suppl 2:14-8.

Can monoamine-based therapies be improved?

Author information

1
Lilly Research Laboratories, Lilly Corporate Center, Drop Code 2066, Indianapolis, IN 46285, USA. madmd@lilly.com

Abstract

Monoamine-based therapies that selectively target serotonin, norepinephrine, or dopamine uptake are effective as antidepressants. However, many depressed patients do not achieve remission with these single-action agents. Treatment strategies that target more than one neurotransmitter, either through augmentation, combination treatment, or the development of single agents with dual or triple reuptake mechanisms, may prove to be even more effective than traditional antidepressants and merit further research.

PMID:
15453009
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Physicians Postgraduate Press, Inc.
    Loading ...
    Support Center